Tolerance of Healthy Term Infants Fed Infant Formulas #3

NCT00977964 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 270

Last updated 2010-11-25

No results posted yet for this study

Summary

The primary objective of this study is to assess the comparative gastrointestinal (GI) tolerance of normal term infants to six experimental milk protein-based powdered infant formulas.

Conditions

  • Gastrointestinal Tolerance

Interventions

OTHER

Experimental milk protein infant formula Process A

ad lib for 1-8 days of age until 28 days of age

OTHER

Experimental milk protein infant formula Process B

ad lib from 1-8 days of age until 28 days of age

OTHER

Experimental milk protein infant formula Process C

ad lib from 1-8 days of age to 28 days of age

OTHER

Experimental milk protein infant formula Process D

ad lib from 1-8 days of age until 28 days of age

OTHER

Experimental milk protein infant formula Process E

ad lib from 1-8 days of age until 28 days of age

OTHER

Experimental milk protein infant formula Process F

ad lib from 1-8 days of age until 28 days of age

Sponsors & Collaborators

  • Abbott Nutrition

    lead INDUSTRY

Principal Investigators

  • Caude T Ashley, MD · Alabama Clinical Therapeutics, LLC

  • Terri L Ashmeade, MD · USF Department of Pediatrics

  • Jay Cohen, MD · Discovery Clinical Research, Inc.

  • Timothy Crum, MD · Rockwood Clinic

  • Cole Ezeoke, MD · North Georgia Clinical Research, White's Pediatrics

  • Sharon Groh-Wargo, PhD, RD, LD · MetroHealth Medical Center

  • James Guerrieri, MD · Institute of Clinical Research, LLC

  • James Hedrick, MD · Kentucky Pediatric Research

  • Jeffrey Hirschfield, MD · SCORE Physician Alliance, LLC

  • Kevin Mullen, MD · Medical Associates Clinic, PC

  • Chris Peltier, MD · Pediatric Associates of Mount Carmel, Inc.

  • Martin J Schear, MD · Dayton Clinical Research

  • Julie Shepard, MD · Ohio Pediatric Research Association

  • William Stepp, MD · Sarah Cannon Research Institute, LLC

  • L Louise Tetrick, MD · Northpoint Pediatrics

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Max Age
8 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2010-01-31
Completion
2010-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00977964 on ClinicalTrials.gov